Exploratory Study Into Age-related Immunological Differences Related to Immunogenicity in Influenza Vaccination and Herpes Zoster Vaccination
Latest Information Update: 17 Jul 2023
At a glance
- Drugs GSK 137173A (Primary) ; Influenza virus vaccines (Primary)
- Indications Herpes zoster; Influenza virus infections
- Focus Pharmacodynamics
- 28 Jun 2023 Status changed from active, no longer recruiting to completed.
- 19 May 2022 Status changed from recruiting to active, no longer recruiting.
- 11 Jan 2022 Planned primary completion date changed from 16 Dec 2022 to 21 Apr 2023.